Aurinia Pharmaceuticals Inc (AUPH) stock forecast — our track record

Lyra published 11 AUPH stock forecasts starting on July 11, 2025. Every prediction used the short term (0 to 3 months) horizon. Each forecast was published before its outcome was known, and all 11 were later closed and scored. Their evaluation windows ran through October 6, 2026, so the track record covered completed outcomes rather than open calls.

Ten forecasts reached their targets. There were no misses, while one forecast received a partial result. The average success score was 90.9%. Because every call used the same short-term horizon, there was no medium-term or long-term performance to compare. The short-term forecasts also had an average peak gain of 25.8%.

The best call was published on July 11, 2025. It predicted 38% growth over the short term. The stock rose as much as 51.6% and reached the target in 35 days, earning a 100% score. The weakest call was published on November 4, 2025. It predicted 22% growth, but the stock rose as much as 4.1% and did not reach the target. That call received a 50% score. Overall, most of Lyra's AUPH calls reached their targets, and the average score was high, though the November 4 prediction fell well short of its forecast.